STAT+: A year after distressed buyout, what’s become of Bluebird Bio?
Bluebird Bio was a dark biotech morality tale when David Meek bought it.
He says the new company, Genetix, is already making money.
Bluebird Bio was a dark biotech morality tale when David Meek bought it.
He says the new company, Genetix, is already making money.